microRNAs (miRNAs) are potent regulators of gene expression that function in diverse developmental and physiological processes. Argonaute proteins loaded with miRNAs form the miRNA Induced Silencing Complexes (miRISCs) that repress gene expression at the post-transcriptional level. miRISCs target genes through partial sequence complementarity between the miRNA and the target mRNA's 3' UTR. In addition to being targeted by miRNAs, these mRNAs are also extensively regulated by RNA-binding proteins (RBPs) through RNA processing, transport, stability, and translation regulation. While the degree to which RBPs and miRISCs functionally interact to regulate gene expression is likely extensive, we have only begun to unravel these functional interactions. An
Introduction
Robust regulation of gene expression is essential for normal development and cellular homeostasis. microRNAs (miRNAs), small non-coding RNAs ~22nt in length, negatively regulate gene expression at the post-transcriptional level. miRNAs can act as developmental switches or can fine tune the expression of the target genes (for review, see [1] , [2] ). Processed miRNAs are loaded into their main protein cofactor, Argonaute (AGO), which then associates with members of the GW182 family of proteins, forming the microRNA Induced Silencing Complex (miRISC). Mature miRISCs bind to the target messenger RNAs (mRNAs) and repress their translation and/or destabilize the target mRNA [3] , [4] .
RNA binding proteins (RBPs) make up another class of post-transcriptional gene regulators.
RBPs can affect miRNA gene-repressive activity in a variety of ways, including through miRNA processing [5] and mRNA co-targeting through mRNA processing, transport, localization, stability/degradation and mRNA translation regulation. A given mRNA bound by miRISC also serves as a platform for binding of additional RNA-interacting factors, and a few have been shown to associate with core miRISC and modulate its activity [6] , [7] , [8] . For example, NHL-2 and CGH-1 physically interact with miRISC and enhance the repression of miRNA target genes [7] , a process regulated by casein kinase II [9] . Furthermore, many genes, including RNA binding proteins (RBPs), have been identified as genetic interactors of the let-7 family of miRNAs [10] , [11] , [12] , [13] . It remains unclear how many of them function as direct modulators of miRISC activity. Complementary to these approaches, we have previously sought to identify physical interactors of ALG-1, a miRNAspecific C. elegans Argonaute [14] , hypothesizing that proteins that co-precipitate with ALG-1 include factors that modulate miRNA-induced gene repression. An RNAi-based screen of the putative ALG-1 co-factors has identified HRPK-1, a conserved homolog of human heterogeneous nuclear ribonucleoprotein K (hnRNPK), as a novel miRNA interactor that modulates activity of several binding near miR-122 target sites on target mRNAs [27] . The functional significance of these interactions has not yet been described. In C. elegans, two KH domain-containing proteins, GLD-1 and VGLN-1 have been shown to genetically and/or physically interact with miRNA machinery [28] and [24] , respectively. The mechanism through which GLD-1 and VGLN-1 functionally interact with the miRNA pathways remains unclear.
We have previously identified HRPK-1(F26B1.2), an hnRNPK homolog, in ALG-1 Argonaute immunoprecipitates as a putative ALG-1 physical interactor [14] . Here, we report the characterization of hrpk-1 as a functional miRNA interactor that modulates activity of several miRNAs. Loss of hrpk-1 results in a number of developmental defects, including sterility, embryonic lethality, vulval bursting, loss of alae, and abnormal gonad formation. Genetic loss of HRPK-1 enhances miRNA reduction-offunction phenotypes, consistent with HRPK-1 functional requirement for wild type miRNA activity. We report that HRPK-1 is ubiquitously expressed throughout C. elegans development and localizes to both nuclei and cytoplasm in some tissues, while remaining strongly nuclear in others. We confirm that HRPK-1 co-precipitates ALG-1 by immunoprecipitation. Finally, while hrpk-1 appears to be globally dispensable for miRNA biogenesis, it may play a role in processing of select miRNAs. HRPK-1 is not needed for ALG-1/AIN-1 miRISC assembly, suggesting that HRPK-1 may also functions at the level of miRNA target repression, especially in case of miRNAs whose processing does not depend on HRPK-1 activity.
Our data suggest that HRPK-1 may regulate miRNA activity by interacting with miRNAassociated protein complexes and modulating the efficacy of both mature miRNA processing and miRNA activity on target mRNAs. This furthers our understanding of how miRNAs may be regulated by or function in concert with RNA binding proteins. Our findings also demonstrate that RNA binding proteins may integrate distinct developmental and physiological signals with miRNA-mediated gene repression.
Results
To identify and characterize potential physical and functional interactions of HRPK-1 with miRISC components, we first generated a null allele in hrpk-1. A previously existing deletion allele of hrpk-1, hprk-1(tm5522), causes an in-frame deletion within the hrpk-1 gene, resulting in production of a truncated HRPK-1 protein ( Fig 1A-C ). Using CRISPR/Cas9-based genome editing, we generated two independent null alleles of hrpk-1, hrpk-1(zen15) and hrpk-1(zen17) (Fig1A-C). Both alleles nearly completely or completely delete the hrpk-1 locus ( Fig 1A) and produce no HRPK-1 protein ( Fig   1B-C) . Since both null alleles produce a similar loss-of function phenotype (S1 Fig), we have designated the larger deletion, hrpk-1(zen17), as the reference null allele for hrpk-1 and used it in subsequent analyses.
ALG-1 Argonaute and HRPK-1 co-immunoprecipitate in a partially RNA dependent manner.
We have previously identified HRPK-1(F26B1.2) by immunoprecipitating C. elegans miRNAspecific Argonaute ALG-1 and analyzing the co-purified protein complexes by MudPIT proteomics [14] , ( Fig 1D) . To confirm this physical interaction, we performed reciprocal IP using antisera generated against HRPK-1 and probed for the presence of ALG-1. We found that HRPK-1 IP coprecipitates ALG-1 ( Fig 1E) , consistent with HRPK-1 interaction with the miRNA machinery.
To determine whether HRPK-1/ALG-1 co-immunoprecipitation is RNA dependent, we performed the HRPK-1 IP in the presence of RNAse A (20µg/ml). Interestingly, incubation of lysates with RNAse A prior to and during HRPK-1 IP reduces but does not abolish ALG-1 co-precipitation with HRPK-1 ( Fig 1E) . This result suggests that while the ALG-1/HRPK-1 binding may in part depend on RNA, the two proteins may also be interacting directly, rendering the observed interaction partially RNAse A resistant ( Fig 1E) . The ALG-1/HRPK-1 interaction may be strengthened through RNAprotein interactions.
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hrpk-1 is required for a number of developmental processes.
To determine what effects hrpk-1 mutations have on animal development, we characterized gross morphological phenotypes of both hrpk-1(tm5522) and hrpk-1(zen17) mutants. We found that both alleles induce temperature sensitive sterility (Fig 2A) , embryonic lethality ( Fig 2B) , and reduced brood size ( Fig 2C) . Both alleles also cause gonad formation defects (Fig 2D, E) and vulval bursting in day 3 or older adults ( Fig 2F) . We observed that almost in every instance, homozygous hrpk-1(tm5522) mutants exhibit more severe phenotypes than complete loss of hrpk-1 (Fig 2A- mutant animals also fail to produce adult alae approximately 40% of the time ( Fig 2G) . In addition, hrpk-1 function appears to be maternally required for fertility (S2 Fig A) , brood size (S2 Fig B) , and embryonic viability (S2 Fig C) . Specifically, hrpk-1(zen17) [m-z-] animals have increased defects compared to hrpk-1(zen17) [m+z-] in sterility (S2 Fig A) , brood size (S2 Fig B) , and embryonic lethality (S2 Fig C) .
hrpk-1(tm5522) allele is antimorphic.
Our genetic analysis suggests that hrpk-1(tm5522) allele is weakly semi-dominant and antimorphic in nature (S2 Fig) . Firstly, homozygous hrpk-1(tm5522) mutants almost always exhibit more severe phenotypes than hrpk-1(zen17) null animals (Fig 2A- Fig B) and embryonic lethality (S2 Fig C) and vulval bursting (S2 Fig D) not normally observed in wild type animals. Furthermore, animals carrying a single copy of maternally provided hrpk-1(tm5522) allele (hrpk-1(tm5522)⚥/hrpk-1(zen17)♂ produced by hrpk-1(tm5522) mothers and hrpk-1(zen17) fathers) exhibit higher rates of sterility (S2 Fig A) , have smaller brood sizes (S2 Fig B) , and higher embryonic lethality (S2 Fig C) than hrpk-1(zen17) [m-z-] animals lacking functional hrpk-1 completely. Animals carrying a single copy of maternally provided hrpk-1(tm5522) allele (hrpk-1(tm5522)⚥/hrpk-1(zen17)♂also show more severe phenotypes than hrpk-1(tm5522)♂/ hrpk-1(zen17)⚥ animals produced by hrpk-1(tm5522) fathers and hrpk-1(zen17) mothers (S2 Fig A-C) , likely a result of both the antimorphic nature of the tm5522 allele and the maternal component to its function. Overall, while the genetic analysis is somewhat complex due to the maternal requirement for hrpk-1 activity, taken together, these genetic data support the antimorphic, weakly semi-dominant nature of the hrpk-1(tm5522) allele.
hrpk-1 functionally interacts with the let-7 family of miRNAs.
To test whether hrpk-1 functions in miRNA-dependent cell fate specification, we examined potential genetic interactions between hrpk-1 and let-7 family of miRNAs that control temporal cell fate specification throughout larval development. The let-7 miRNAs regulate the stage specific cell gene expression programs in a number of tissues, with the let-7 family mutant phenotypes most evident in the C. elegans seam and hypodermis (for review, see [29] ). Specifically, let-7 family miRNAs, together with other heterochronic genes, regulate cell division patterns of the seam cells during larval development [30] and seam cell terminal differentiation at the transition from larval development to adulthood [31] . mir-48, mir-241, and mir-84, three members of the let-7 miRNA family, are transcriptionally upregulated in the late L1 stage and subsequently down-regulate the expression of the hbl-1 transcription factor during the L2 stage [30] . As a consequence of these regulatory interactions, mir-48, mir-241, and mir-84 limit the proliferative seam cell division pattern of hypodermal stem cells to the L2 stage and promote subsequent L3-associated patterns of seam cell divisions [30] , ( Fig 3A) . mir-48, mir-241, and mir-84 are genetically redundant, with single and double mutants of these microRNAs exhibiting partially penetrant cell retarded heterochronic phenotypes [30] . These phenotypes can be monitored by observing alterations in seam cell lineage as well as defects associated with a reduction in the expression of adult-specific reporters (col-19::gfp) after the 4 th larval stage [30, 32] , ( Fig 3B) . hrpk-1(zen17) enhances the retarded phenotype of mir-48 mir-241 (nDf51) mutants ( Fig 3B-D) . Specifically, loss of hrpk-1 activity enhances the retarded expression of adult hypodermal marker, col-19::gfp(maIs105), (Fig 3C and D) and results in an increased number of seam cells as compared to mir-48 mir-241(nDf51) alone ( Fig 3B) . This enhancement of the mir-48 mir-241(nDf51) heterochronic phenotype by loss of hrpk-1 is consistent with hrpk-1 functional requirement for efficient activity of the remaining intact let-7 family miRNAs. let-7, the founding member of the let-7 family of miRNAs, controls terminal cell fate specification, which occurs during the developmental progression through the late larval stages and into the adulthood [31] . A temperature sensitive mutation that compromises but does not completely abolish let-7 activity, let-7(n2853), causes a retarded development phenotype [31] , [33] . let-7(n2853) animals have abnormal/absent alae in young adults and delayed hypodermal expression of the adult marker col-19::gfp at 20ºC ( Fig 3E and F) , [31] . hrpk-1 knockout enhances retarded col-19::gfp(maIS105) expression ( Fig 3E) and the retarded alae phenotype ( Fig 3F) observed in the let-7(n2853) mutants. Loss of hrpk-1 alone is not enough to induce a heterochronic phenotype ( Fig 3A, D, C). The observed enhancement of the let-7(n2853) retarded phenotype by hrpk-1 mutations is consistent with the hypothesis that hrpk-1 function is important for let-7 miRNA activity.
hrpk-1 functionally interacts with the lsy-6 miRNA and is required for efficient regulation of
lsy-6 target cog-1.
To test the hypothesis that HRPK-1 may be required for miRNA activity regulation, we looked for the effects of hrpk-1 mutations on the activity of lsy-6 miRNA-dependent processes. lsy-6 regulates cell fates of two bilaterally symmetrical ASE neurons [34] . ASEL-specific expression of lsy-6 down-regulates its key target, cog-1, while uninhibited cog-1 expression within the ASER dictates that neuron's cell fate [34] . The ASEL cell fate is distinguished by the expression of a downstream reporter, Plim-6::gfp, an established marker for the ASEL cell fate [34] , [35] , ( Fig 4A) . Reduction of lsy-6 activity through a cis-regulatory mutation in the lsy-6 promoter, lsy-6(ot150), causes a low penetrance phenotype where the ASEL neuron adopts the cell fate of ASER approximately 20% of the time [36] , ( Fig 4A and B) . To assess hrpk-1-lsy-6 functional interaction we removed hrpk-1 in the presence of the reduction of function lsy-6(ot150) allele. Genetic mutations in hrpk-1 significantly enhance the cell fate defective phenotype observed in the lsy-6(ot150) animals ( Fig 4B) . hrpk-1 mutations alone are not sufficient to induce an ASEL to ASER cell fate switch ( Fig 4B) . Importantly, hrpk-1 RNAi relieves the lsy-6-mediated inhibition of its target, cog-1::gfp, in uterine cells ( Fig 4C-D) , suggesting that HPRK-1 is required for efficient inhibition of cog-1 by lsy-6 miRNA in that tissue.
hrpk-1 functionally interacts with the mir-35-42 family of miRNAs.
To assess whether hrpk-1 may be broadly required for miRNA activity, we reduced its function in other miRNA sensitized backgrounds. Combining either hrpk-1 deletions (hrpk-1(zen17) and hrpk-1(tm5522)) with the mir- [35] [36] [37] [38] [39] [40] [41] deletion allele results in a strong synthetic lethal phenotype where a majority of animals fail to develop ( Fig 5A) . This genetic synergy in combined mutants is also recapitulated in a dramatic decrease in overall brood size ( Fig 5B) . In both cases, animals were reared at the semi-permissive temperature of 20ºC. hrpk-1(tm5522) causes a greater enhancement of the mir- [35] [36] [37] [38] [39] [40] [41] phenotype than hrpk-1(zen17) null ( Fig 5 A-B) , consistent with the antimorphic nature of the hrpk-1(tm5522) allele. Importantly, the enhancement of the mir-35-41(nDf50) phenotype by hrpk-1 mutations is not simply additive, but synergistic ( Fig 5A-B) , consistent with the hypothesis that hrpk-1 activity may be required for remaining miR-42 function.
HRPK-1 is ubiquitously expressed throughout C. elegans development.
To gain insight into HRPK-1 function, we characterized both spatial and temporal expression of endogenous HRPK-1 using a CRISPR-generated hrpk-1::gfp transgene ( Fig 6) . hrpk-1::gfp is ubiquitously expressed during all C. elegans developmental stages ( Fig 6A-D) . The C-terminally tagged hrpk-1::gfp expression is observed in the gut, muscle, neuronal, and hypodermal tissues, where it localizes to the cell nuclei ( Fig 6A, B) . Interestingly, hrpk-1::gfp is strongly present in the animal germline, oocytes, and early embryos, where its subcellular localization is both nuclear and cytoplasmic ( Fig 6B-D) . The subcellular localization of HRPK-1::GFP is consistent with the predicted nuclear localization and nuclear export signals found within the hrpk-1 sequence ( Fig 1B) . Our inability to detect hrpk-1::gfp signal in the cytoplasm of somatic cells may reflect HRPK-1 distinct functions between the soma and the germline or may simply be due to a lower expression level that falls below our detection limits. In fact, HRPK-1 somatic cytoplasmic localization has been observed large scale subcellular proteome mapping [39], suggesting that we may be limited in detecting HRPK-1 in the cytoplasm in the presence of strong nuclear expression. Overall, the spatial and temporal hrpk-1 pattern of expression is consistent with the apparent hrpk-1 roles in a number of developmental processes, including embryonic and larval development, as well as fertility.
Loss of hrpk-1 modestly affect levels of select miRNAs but does not affect ALG-1/AIN-1 miRISC assembly.
Functional regulation of the miRNA activity by HRPK-1 could occur at the level of miRNA processing, miRISC assembly, or miRISC activity. To determine whether HRPK-1 is necessary for miRNA biogenesis, we cloned and sequenced miRNAs from wild type, hrpk-1(zen17), and hrpk-1(tm5522) mutant animals. We found that in general, abundance of mature miRNAs is not globally affected in hrpk-1(zen17) animals ( Fig 7A- C, S1 Table) , with only five mature miRNAs reduced 2 or more-fold in hprk-1(zen17) mutant and three miRNAs increased more than 2-fold (S2 Table) . In contrast, hrpk-1(tm5522) animals have an expanded set of miRNAs reduced in abundance. Twentyseven miRNAs, including members of the mir-35 family, were reduced 2-fold or more in the hrpk-1(tm5522) animals, and seven miRNAs were increased in abundance in htpk-1(tmm5522) mutants (S2 Table) . We did observe a >2-fold decrease in lsy-6 abundance in both hrpk-1(zen17) and hrpk-1(tm5522) animals ( Fig 7D and S2 Table) . This reduction in lsy-6 counts could explain the functional interaction observed between hrpk-1(-) and lsy-6(ot150). In contrast, let-7, mir-84, and mir-42 levels were not consistently decreased in hrpk-1 mutants ( Fig 7D and S1 Table) . In fact, mir-84 counts were somewhat increased in both hrpk-1(zen17) and hrpk-1(tm5522) animals and let-7 and mir-42 were slightly decreased in the hrpk-1(tm5522) mutants only ( Fig 7D and S1 Table) . These data suggest that the functional interaction between hrpk-1 mutations and let-7(n2852), mir-48 mir-241(nDf51), and mir-35-41(nDf50) miRNA mutants does not arise from a decrease in miRNA abundance of the remaining intact miRNAs (let-7, mir-84, and mir-42).
Mature miRISC formation involves Argonaute association with GW182 homologs [4] . To assess whether HRPK-1 may be needed for miRISC assembly, we tested the ability of ALG-1 to coprecipitate with its miRISC co-factor and GW182 homolog AIN-1 in hrpk-1(zen17). We found that AIN-1 co-precipitates with ALG-1 in hrpk-1 mutant animals at levels similar to those observed in wild type ( Fig 7E) . We did not test for ALG-2 and AIN-2 containing miRISC formation and therefore cannot rule out the possibility that HRPK-1 may be necessary for formation of miRISCs that include ALG-2 and/or AIN-2 proteins. However, we can conclude that HRPK-1 is not required for ALG-1/AIN-1 interaction as observed by our ALG-1 immunoprecipitation experiments ( Fig 7E) .
Discussion
HRPK-1 physically and functionally interacts with miRNA pathways.
In this manuscript we report characterizations of hrpk-1, which encodes an RNA binding protein HRPK-1. HRPK-1 was originally identified by MudPIT proteomics in ALG-1 co-precipitates [14] , ( Fig 1D) . Here, we confirm that HRPK-1 can co-precipitate ALG-1 in a reciprocal experiment and show that the interaction between HRPK-1 and ALG-1 is only partially RNA-dependent (Fig1E). The relatively small amount of ALG-1 co-precipitating with HRPK-1 could reflect instability of complexes in our assay or may represent the portion of ALG-1 in complex with HRPK-1 ( Fig 1E) . Importantly, not only is HRPK-1 a conserved protein and an ortholog of human hnRNP K, the interaction between Argonaute and HRPK-1 also appears to be conserved as hnRNP K has previously been co-purified with three of four human AGO proteins [40] .
In addition to confirming the conserved physical interaction between HRPK-1 and ALG-1, we report that hrpk-1 is genetically required for efficient activity of several miRNAs and miRNA families: lsy-6, let-7-family, and mir-35-family. Loss of hrpk-1 alone does not alter ASEL/ASER cell fate decisions despite enhancing the lsy-6(ot150) reduction-of-function phenotype. In addition to enhancing the cell fate defects observed in lsy-6(ot150) animals, HRPK-1 promoted lsy-6 mediated repression of lsy-6 target gene, cog-1 (Fig 4C and D) . Similarly, loss of hrpk-1 did not cause a heterochronic phenotype normally observed in let-7 family mutants (Fig 3) , although the antimorphic hprk-1(tm5522) allele did produce a mild alae defect ( Fig 2G) . Together, these data suggest that HRPK-1 is not an essential miRNA co-factor, but rather positively modulates lsy-6 and let-7 family miRNA activity. The synergistic genetic interaction between hrpk-1 mutations and mir- [35] [36] [37] [38] [39] [40] [41] is also consistent with a hypothesized role for hrpk-1 as a positive co-factor of mir-42 activity. Overall, we show that HRPK-1 physically interacts ALG-1, a major component of miRLC/miRISC and functionally interacts with several miRNAs in a number of developmental processes.
hrpk-1 subcellular localization
Overall, the ubiquitous expression of hrpk-1 is consistent with its pleotropic effects on C. elegans development. We observed a strong nuclear expression of endogenous hrpk-1 ( Fig 6) and both nuclear and cytoplasmic HRPK-1::GFP localization in the germline, oocytes, and early embryos. This is not surprising as HRPK-1 does contain a predicted nuclear localization signal and a predicted nuclear export signal ( Fig 1B) . Despite our inability to definitively detect HRPK-1::GFP in the cytoplasm of somatic tissues, a recent report mapping the subcellular-specific proteomes in a number of C. elegans tissues places HRPK-1 in the hypodermal cytoplasm in addition to the nucleus using a proximity ligation dependent assay [39]. This assay may be able to capture transient protein shuttling and likely has a higher sensitivity than our fluorescent reporter observations. We would argue that the observed steady-state nuclear HRPK-1::GFP localization does not mean there is no function for HRPK-1 in the cytoplasm. In fact, given the biochemical interaction between ALG-1 and HRPK-1, we hypothesize that cytoplasmic HRPK-1 activity may in fact be required for its functional interaction with the miRNA pathways. It remains to be seen whether nuclear HRPK-1 localization or movement between the nucleus and the cytoplasm plays a role in miRNA-dependent gene expression regulation.
How might HRPK-1 enhance miRNA gene repressive activity?
Overall, several molecular models can explain the genetic and physical interactions between HRPK-1 and miRNA machinery. It is possible that HRPK-1 may interact with ALG-1 at the miRNA Loading Complex (miRLC) and participate in mature miRNA biogenesis ( Fig 8A) . We observed miRNA abundance changes for a small subset of miRNAs, including lsy-6, in hrpk-1 mutant animals ( Fig 7A-D and S2 Table) . The observed functional interaction between hrpk-1 and lsy-6 mutations could therefore be explained by a reduced abundance of lsy-6 miRNA, potentially placing HRPK-1 in the lsy-6 processing pathway. However, the abundances of the majority of miRNAs, including the let-7-family and mir-42 were not consistently decreased between wild type and hprk-1 mutants (S1 Table   and Fig 7A-D) . This observation suggests that the functional interaction between hrpk-1 mutants and let-7(n2853), mir-48 mir-241(nDf51), and mir- [35] [36] [37] [38] [39] [40] [41] (Figs 3 and 5 ) is likely not due to hrpk-1(-) effects on miRNA processing. In fact, most mature miRNA abundances are not affected in hrpk-1(zen17) animals ( Fig 7A- C, S1 Table) . HRPK-1 involvement at the level of miRLC may therefore be limited to a small subset of miRNAs, including lsy-6. However, we cannot at this point rule out the possibility that HRPK-1 may play a broader role in miRLC formation or miRNA processing. The greater reduction of miRNA numbers in hrpk-1(tm5522) compared to hrpk-1(zen17) mutants hints at a possible explanation for the more severe phenotypes observed in hrpk-1(tm5522) animals, potentially through sequestration of components essential for miRNA processing or stability. Further work will be needed to characterize the extent to which HRPK-1 may be involved in miRNA processing and/or stability and the cause of the antimorphic nature of the hrpk-1(tm5522) allele.
We found that HRPK-1 is not required for ALG-1/AIN-1 miRISC assembly, as hrpk-1(zen17) animals have an intact ALG-1/AIN-1 miRISC ( Fig 7E) . This observation is consistent with the hypothesis that HRPK-1 may interact with ALG-1 downstream of miRISC formation, possibly via the target mRNAs. We favor this hypothesis, as it is difficult to imagine a sole role for HRPK-1 at the level of miRLC that does not globally affect mature miRNA biogenesis or mature miRISC formation.
Interestingly, the interaction between HRPK-1 and ALG-1 is only partially RNA-dependent ( Fig 1E) , suggesting that RNA is not necessary for this interaction to occur but may enhance it. HRPK-1 is a member of the KH domain family of proteins, which are known to be RNA binding proteins with diverse functions. These functions could include roles in mRNA processing, mRNA stability and folding, and mRNA transport out of the nucleus, and translational control. It is possible that, similar to other hnRNP proteins, HRPK-1 has diverse functions and may coordinate with miRNA pathways on multiple levels, perhaps even by bridging the miRLC with miRISC. In addition to a potential role in miRNA processing for subset of miRNAs ( Fig 8A) , HRPK-1 may stimulate miRNA/miRISC activity by increasing miRNA target site availability through mRNA folding ( Fig 8B) . In this model, HRPK-1 association with target mRNAs and miRISC may enhance miRISC accessibility and binding to target mRNAs and therefore increase the target gene repression ( Fig 8B) . In addition, HRPK-1 could stimulate the interaction between miRISC and downstream effector complexes ( Fig 8C) . Identification of HRPK-1 RNA binding sites and their proximity to miRNA target sites will in the future help characterize the physical relationship between the two.
Given the diversity of hnRNP and KH domain proteins functions, we must allow for the possibility that multiple, miRISC-dependent and independent HRPK-1 activity synergizes with the miRNA-mediated target regulation. For example, an HRPK-1 role in mRNA processing could increase miRNA site availability. Identifying the impacts of HRPK-1 loss on alternative splicing of mRNAs and the resulting changes in miRNA binding site availability can in the future shed light on the plausibility of this model. It should be noted that none of the proposed models are mutually exclusive and multiple HRPK-1 functions could synergize, directly and/or indirectly, with the miRNA gene regulatory pathways. We look forward to further investigating the mechanisms through which HRPK-1 and miRNAs cooperate to facilitate gene repression.
Overall, our results demonstrate that HRPK-1, a KH domain RNA binding protein, physically and functionally interacts with miRNA-mediated gene repression. Other KH domain RNA binding proteins have been shown to biochemically and genetically interact with the miRNA machinery. These include the C. elegans translational repressor, a Quaking homolog, and a KH domain protein, GLD-1, among others [28] , [41] and VGLN-1 [24] . Additional KH-domain proteins and other hnRNPs have been detected in large-scale mass spectrometry experiments [41], [14] , [42] . The molecular mechanisms by which RNA binding proteins synergize with miRNA pathways to regulate mRNA expression are diverse and remain largely unknown. Further studies to understand the mechanism of functional interactions between RBPs, including HRPK-1, and miRNA-mediated gene repression will shed light on how these two classes of post-transcriptional gene regulators cooperate to regulate animal development.
Materials and methods
Strain maintenance, RNAi, and phenotypic assessments
C. elegans strains were grown in standard conditions on NGM plates using OP50 as a food source [43] . Strains were maintained at 20ºC unless otherwise noted. RNAi gene knockdown was performed as previously described [44] . Briefly, PS3662 or OH7310 animals were placed on hrpk-1
RNAi food and the F1 progeny were scored for the cog-1::gfp presence in vulval and uterine cells.
For the mir-48 mir-241(nDf51) assay, young adults were scored for seam and hypodermal col-19::gfp expression, alae formation, and seam cell number. Seam cells numbers were obtained by counting the seam cells located between the pharynx and the anus of a given animal. Phenotypes were scored on either the Zeiss Axioplan 2 or the Leica DM6 upright microscopes equipped with DIC and epifluorescence. For mir-35-41(nDf50) assay, animals were scored for sterility, brood size and embryonic lethality. Animal sterility, embryonic lethality, and brood size were assessed by scoring entire broods of individual animals. Animals were considered sterile if they were unable to produce any progeny, dead or alive. Brood size refers to the total number of progeny produced, including dead embryos. Percent embryonic lethality was calculated as follows: # of dead embryos/total progeny (live progeny + dead embryos). Vulval bursting was visually assessed beginning at the Day 1 young adult stage and daily thereafter.
CRISPR-based genome editing
hrpk-1(zen15) and hrpk-1(zen-17) deletion alleles were produced using CRISPR/Cas9 genome editing using hrpk-1 site specific guides 1 and 9, corresponding to the 5' and 3' ends of the gene, respectively. The following hrpk-1 guides were used to generate the deletions: hrpk-1 guide 1, ACTGTCTGTTCCATTAATAG and hrpk-1 guide 9, CAAGGCCGTGAACGATTCGG. hrpk-1(zen17) was outcrossed seven times and hrpk-1(zen15) was outcrossed twice. The entire hrpk-1 locus was sequenced to confirm the nature of the deletion in each mutant.
Endogenously tagged hrpk-1::gfp strains were generated by inserting a worm codon-optimized GFP coding sequence and a self-excising cassette (SEC) into the C-terminus of endogenous hrpk-1 locus just before the stop codon through CRISPR/Cas-9 triggered homologous recombination [45] .
The SEC was then excised as described [45] . The donor sequence was generated by subcloning 596 bp upstream of the hrpk-1 stop codon and 600 bp downstream of hrpk-1 stop codon into the pDD282 vector [45] using Hi Fi assembly kit (NEB). The hrpk-1 stop codon was eliminated from the donor sequence to allow in frame GFP tag addition. A PAM site mutation corresponding to guide 9 was included in the donor DNA sequence resulting in the sequence change of
[CAAGGCCGTGAACGATTCGGTGG] change to [CAAGGCCGTGAACGATTCGGTCG] immediately upstream of the GFP tag sequence. Animal microinjections were performed as previously described [46] . Six independent hrpk-1::gfp lines were obtained and the resulting endogenously tagged hrpk-1::gfp loci was sequenced. Since all six lines looked superficially wild type and showed the same hrpk-1::gfp expression pattern, a single line was chosen for an in-depth analysis. The hrpk-1::gfp(zen64) strain was outcrossed twice and assessed for hrpk-1 functional integrity. hrpk-1::gfp transgenic line had wild type fertility and embryonic viability (S3 Fig), confirming that the GFP-tagged HRPK-1 retained its wild type activity.
The following primers were used in generation of the hrpk-1 donor sequence in order to place the GFP sequence at the C-terminus of hrpk-1: 
Extract preparation and immunoprecipitation (IP)
Worm extracts were prepared as previously described [47] with the following modifications.
Mixed stage animals were homogenized using a Bullet blender (MIDSCI). Briefly, 300µL worm pellets were mixed with RNAse free Rhino beads (MIDSCI) and 300µL lysis buffer and homogenized at the highest setting for 4 minutes. Homogenate was then moved to a fresh tube and spun at 13,000xg for 20 minutes to clarify the extract. The extracts were then used for immunoprecipitation experiments or were flash frozen in liquid nitrogen and stored at -80ºC. ALG-1 immunoprecipitation and Western blotting were performed as previously described [48] using Protein A Dynabeads (ThermoFisher). HRPK-1 detection was done using a custom rabbit anti-HRPK-1 antibody (Pocono) generated against the C-terminal peptide of HRPK-1 (CVRNSTQGRERFGGSV) at the 1:1000 dilution. HRPK-1 immunoprecipitation was performed using the same method as ALG-1 immunoprecipitation [48] , with the anti-HRPK-1 antibody covalently crosslinked to the Protein A Dynabeads (ThermoFisher) using dimethylpimelimidate1. Mouse antitubulin antibody (Sigma-Aldrich) was used to detect tubulin as a loading control.
RNA preparation and small RNA sequencing
RNA from mixed stage animals was prepared as previously described [47] with the following modifications. Mixed stages animals resuspended in 250µL water were mixed with 1ml of Trizol (Fisher Scientific) and RNAse free Rhino beads (MIDSCI) and homogenized using a Bullet blender (MIDSCI) at the highest setting for 4 minutes. Homogenate was then moved into a fresh tube, mixed with 212µL of chloroform, and spun down to separate the phases. All remaining steps of the RNA purification were performed as previously described [47] .
For small RNA libraries preparation, small RNAs were first size selected by gel purification as described in [49] . The size selected RNA was then used to construct small RNA libraries using the NEXTflex Small RNA Library Prep kit v3 (Bioo Scientific) and sequenced on the Illumina HighSeq instrument at the Kansas University Genome Sequencing Core. Data analysis was performed as previously described [14] . The total mapped reads across two replicates were as follows: N2 (7,386,035), UY38 (7, 679, 177) , and UY42 (7, 540, 761) .
Microscopy and statistics
Localization of the endogenously tagged HRPK-1::GFP transgene was imaged using Zeiss Axioplan 2 upright microscope equipped with a Zeiss Axiocam HR digital camera. Images were assembled using Photoshop. Contrast and brightness of images were not adjusted. F-test was used to analyze brood size, t-test was used to analyze embryonic lethality, and chi-square was used to analyze all other phenotypic data. 6. Endogenously tagged hrpk-1::gfp transgene (hrpk-1(zen64) ) is expressed throughout C. Fig. hrpk-1(zen17) and hrpk-1(zen15) show similar phenotypes. hrkp-1(zen15) and hrpk-1(zen17) produce similar levels of sterility (A), embryonic lethality (B), and brood size (C). An increase in embryonic lethality in hrpk-1(zen15) mutant animals (D) is most likely due the difference in the number of outcrosses between the strains, with hrpk-1(zen17) being outcrossed seven times, while hrpk-1(zen15) was outcrossed only twice. ***p≤0.001 S2 Fig. hrpk-1(tm5522) is weakly semi-dominant and hrpk-1 is required maternally. Genetic analyses of hrpk-1(zen17) and hrpk-1(tm5522) alleles reveal that hrpk-1 activity has a maternal component for some developmental processes such as fertility (A), brood size (B), and embryonic viability (C), but not for vulval integrity in day 3 or older adults (D). hrpk-1(tm5522) appears to be weakly semi-dominant as evidenced by the presence of defects observed in hrpk-1(tm5522)/+ and hrpk-1(tm5522)/hrpk-1(zen17) animals (A-D). Genotype of the score animals is shown. m-indicates that scored animals came from homozygous mutant mothers, m+ indicates that scored animals were progeny of wild type mothers. hrpk-1(tm5522)m/hrpk-1(zen17)p animals came from a cross between hrpk-1(tm5522) mothers and hrpk-1(zen17) fathers. hrpk-1(tm5522)p/hrpk-1(zen17)m animals came from hrpk-1(zen17) mothers and hrpk-1(tm5522) fathers. miRNAs with ≥2-fold decreased abundance are highlighted in gray. miRNAs whose abundace increased in hrpk-1 mutants ≥2-fold are highlighted in blue. Table S2 . Mature miRNAs whose abundance was changed 2-fold or more in hrpk-1 mutants compared to wild type.
Strains used in this study
